[Identification of the molecular bases of metastasis for the development of new therapy strategies of metastatic prostate carcinoma].
Schenck
M
M
Molekularbiologische und urologische Forschergruppe, Urologische Universitätsklinik Essen, Hufelandstrasse 55, 45122 Essen. marcus.schenck@uk-essen.de
Boergermann
C
C
vom Dorp
F
F
Busch
Y
Y
Groneberg
M
M
Wilker
B
B
Keitsch
S
S
Moyrer
S
S
Schmid
K W
KW
Stuschke
M
M
Ruebben
H
H
Gulbins
E
E
D000818:Animals; D014408:Biomarkers, Tumor / Q000235:genetics*; D001706:Biopsy; D004260:DNA Repair / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D018816:Genes, cdc; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis / Q000235:genetics* / Q000473:pathology; D008297:Male; D051379:Mice; D016513:Mice, SCID; D009368:Neoplasm Transplantation / Q000473:pathology; D009360:Neoplastic Cells, Circulating; D014411:Neoplastic Stem Cells / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000235:genetics / Q000473:pathology; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000628:therapy*; D011836:Radiation Tolerance / Q000235:genetics
D014408:Biomarkers, Tumor